Aquinox Pharmaceuticals - 5 Year Stock Price History | AQXP

Historical daily share price chart and data for Aquinox Pharmaceuticals since 2014 adjusted for splits. The latest closing stock price for Aquinox Pharmaceuticals as of July 18, 2019 is 2.47.
  • The all-time high Aquinox Pharmaceuticals stock price is 22.13, which is 796% above the current share price.
  • The Aquinox Pharmaceuticals 52-week high stock price is 3.26, which is 32% above the current share price.
  • The Aquinox Pharmaceuticals 52-week low stock price is 2.07, which is 16.2% below the current share price.
  • The average Aquinox Pharmaceuticals stock price for the last 52 weeks is 2.60.
Aquinox Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.5363 2.3300 2.7900 2.2300 2.4700 14.35%
2018 8.0299 12.0000 16.5500 2.0700 2.1600 -81.63%
2017 14.4732 16.2000 19.7600 10.0800 11.7600 -28.77%
2016 10.2919 12.3300 17.7700 6.1600 16.5100 32.29%
2015 10.6295 7.6300 22.1300 1.4600 12.4800 66.40%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.058B $0.025B
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $53.120B 9.67
Mylan (MYL) United Kingdom $9.201B 4.02
Bausch Health Cos (BHC) Canada $8.129B 5.55
Teva Pharmaceutical Industries (TEVA) Israel $7.962B 3.12
Dr Reddy's Laboratories (RDY) India $6.363B 23.80
ASPEN PHARMACR (APNHY) South Africa $3.204B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.693B 16.92
Amphastar Pharmaceuticals (AMPH) United States $0.939B 52.50
Homology Medicines (FIXX) United States $0.911B 0.00
Voyager Therapeutics (VYGR) United States $0.904B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.605B 0.90
Akorn (AKRX) United States $0.487B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.453B 0.00
CymaBay Therapeutics (CBAY) United States $0.442B 0.00
Assembly Biosciences (ASMB) United States $0.357B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.250B 0.00
Sol-Gel Technologies (SLGL) Israel $0.184B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.166B 0.00